ACR guidance document for safe MR practices: 2007.

E. Kanal is a consultant for, is a member of the speakers bureau of, and provides research support for Bracco Diagnostics and GE Healthcare; is a member of the speakers bureau of and provides research support for Siemens Medical Solutions; and provides research support for Berlex and Medtronic. T. Gilk is a consultant for Mednovus, Inc. J. R. Gimbel provides research support for St. Jude Medical, Medtronic, and Biotronik. J. Nyenhuis is a consultant for and provides research support to Medtronics. J. Weinreb is a consultant and member of the speakers bureau for GE Healthcare.

[1]  Harold I Feldman,et al.  Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  H. Alkadhi.  Morphology and beyond: CT of cardiac valves , 2008 .

[3]  Clark D Wiginton.  Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis. , 2008, AJR. American journal of roentgenology.

[4]  L. Nallamshetty,et al.  ACR appropriateness criteria on recurrent symptoms following lower-extremity angioplasty. , 2008, Journal of the American College of Radiology : JACR.

[5]  E. Kanal,et al.  Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. , 2008, AJR. American journal of roentgenology.

[6]  J. Provenzale.  Nephrogenic systemic fibrosis: some considerations on the debate regarding its cause. , 2008, AJR. American journal of roentgenology.

[7]  D. Farine,et al.  Adnexal Masses in the Pregnant Patient: A Diagnostic and Management Challenge , 2008, Ultrasound quarterly.

[8]  H. Thomsen,et al.  Update on nephrogenic systemic fibrosis. , 2008, Magnetic resonance imaging clinics of North America.

[9]  Daniela Prayer,et al.  Prenatal ultrasound and fetal MRI: the comparative value of each modality in prenatal diagnosis. , 2008, European journal of radiology.

[10]  M. Schweitzer,et al.  Current concepts in imaging diabetic pedal osteomyelitis. , 2008, Radiologic clinics of North America.

[11]  H. Sostman,et al.  Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). , 2008, Seminars in nuclear medicine.

[12]  F. Shellock,et al.  MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. , 2008, AJR. American journal of roentgenology.

[13]  A. Ramesh,et al.  A review of the management of gallstone disease and its complications in pregnancy. , 2008, American journal of surgery.

[14]  J. Stoker,et al.  Magnetic resonance imaging and the acute abdomen , 2008, The British journal of surgery.

[15]  R. Halvorsen.  Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging. , 2008, Radiology.

[16]  J. Weinreb.  Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT? , 2008, Radiology.

[17]  F. Shellock,et al.  MRI safety update 2008: part 2, screening patients for MRI. , 2008, AJR. American journal of roentgenology.

[18]  U. Linsenmaier,et al.  Aktuelle bildgebende Diagnostik der Wirbelsäulenerkrankungen , 2008, Der Chirurg.

[19]  Martin R Prince,et al.  Incidence of nephrogenic systemic fibrosis at two large medical centers. , 2008, Radiology.

[20]  N. Moghbeli,et al.  Practical assessment of maternal cardiovascular risk in pregnancy. , 2008, Congenital heart disease.

[21]  Sam S. Chang,et al.  Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. , 2008, The Journal of urology.

[22]  A. Molen.  NEPHROGENIC SYSTEMIC FIBROSIS AND THE ROLE OF GADOLINIUM CONTRAST MEDIA , 2008 .

[23]  W. Bradley.  Pros and cons of 3 tesla MRI. , 2008, Journal of the American College of Radiology : JACR.

[24]  Catherine C Roberts,et al.  ACR Appropriateness Criteria®on Suspected Osteomyelitis in Patients With Diabetes Mellitus , 2008 .

[25]  W. Bradley,et al.  Off-site teleradiology: the pros. , 2008, Radiology.

[26]  F. Coakley,et al.  Guidelines for Computed Tomography and Magnetic Resonance Imaging Use During Pregnancy and Lactation , 2008, Obstetrics and gynecology.

[27]  J. Hand.  Modelling the interaction of electromagnetic fields (10 MHz–10 GHz) with the human body: methods and applications , 2008, Physics in medicine and biology.

[28]  G. Bayliss,et al.  Renal failure and abdominal pain as the presenting symptoms of a rare tumor of the aorta masquerading as a calcified plaque , 2008, NDT plus.

[29]  G. Raskob,et al.  Challenges in the diagnosis of acute pulmonary embolism. , 2008, The American journal of medicine.

[30]  J. Gimbel.  Magnetic Resonance Imaging of Implantable Cardiac Rhythm Devices at 3.0 Tesla , 2008, Pacing and clinical electrophysiology : PACE.

[31]  E. Lancelot,et al.  Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. , 2008, Toxicology.

[32]  A. Panigrahy,et al.  Fetal magnetic resonance imaging: the basics. , 2008, Pediatric annals.

[33]  R. Cury,et al.  Cardiac valve disease: spectrum of findings on cardiac 64-MDCT. , 2008, AJR. American journal of roentgenology.

[34]  A. Oto,et al.  Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. , 2008, AJR. American journal of roentgenology.

[35]  C. Robic,et al.  Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review , 2008, BioMetals.

[36]  Ian G. Ross,et al.  Feasibility of Magnetic Resonance Imaging in Patients with an Implantable Loop Recorder , 2008, Pacing and clinical electrophysiology : PACE.

[37]  H. Hussain,et al.  Nephrogenic systemic fibrosis: a report of 29 cases. , 2008, AJR. American journal of roentgenology.

[38]  P J Rossman,et al.  Vibration safety limits for magnetic resonance elastography , 2008, Physics in medicine and biology.

[39]  J. Topf,et al.  Nephrogenic Fibrosing Dermopathy , 2008, TheScientificWorldJournal.

[40]  V. Ho.  ACR appropriateness criteria on suspected congenital heart disease in adults. , 2008, Journal of the American College of Radiology : JACR.

[41]  R. Rodby.  NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Dialytic Therapies to Prevent NSF Following Gadolinium Exposure in High‐Risk Patients , 2008, Seminars in dialysis.

[42]  R. Reilly,et al.  NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis Risk: Is There a Difference between Gadolinium‐Based Contrast Agents? , 2008, Seminars in dialysis.

[43]  E. Kanal,et al.  Gadolinium‐induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury , 2007, The British journal of dermatology.

[44]  R. P. Guillerman,et al.  Pediatric abdominal magnetic resonance angiography. , 2008, Seminars in roentgenology.

[45]  A. Abu-Alfa.  The impact of NSF on the care of patients with kidney disease. , 2008, Journal of the American College of Radiology : JACR.

[46]  D. Coplen.  Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned , 2007 .

[47]  Sonja K. Robb-Belville.  Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis (NFD/NSF) and Gadolinium-Based Magnetic Resonance Contrast Agents (GBMCAs): A Literature Review , 2007 .

[48]  R. Reilly,et al.  What nephrologists need to know about gadolinium , 2007, Nature Clinical Practice Nephrology.

[49]  C. Partain.  Focus on MR safety , 2007 .

[50]  E. Merkle,et al.  Practice patterns in imaging of the pregnant patient with abdominal pain: a survey of academic centers. , 2007, AJR. American journal of roentgenology.

[51]  D. Reede,et al.  Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[52]  E. Kanal,et al.  Response to "Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?". , 2007, AJR. American journal of roentgenology.

[53]  G. Saab,et al.  Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration? , 2007, AJR. American journal of roentgenology.

[54]  R. Fennell,et al.  Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients , 2007, Pediatric Nephrology.

[55]  J. Leyendecker,et al.  Kidneys and MR urography. , 2007, Magnetic resonance imaging clinics of North America.

[56]  E. Eger.  Brain magnetic resonance imaging increases core body temperature in sedated children. , 2007, Anesthesia and analgesia.

[57]  A. Alavi,et al.  The Role of CT, MR Imaging, and Ultrasonography in Endocrinology. , 2007, PET clinics.

[58]  P. Wilcox,et al.  Quality care and safety know no borders , 2007, Biomedical imaging and intervention journal.

[59]  R. Stanley.  Our Practice of Radiology: Reflections on its Growth and Stature , 2007 .

[60]  A. V. Moore.  Commentary on “ACR Guidance Document for Safe MR Practices: 2007” , 2007 .

[61]  B. K. Stewart,et al.  Safe MR practices: self-assessment module. , 2007, AJR. American journal of roentgenology.

[62]  E. Kanal,et al.  Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. , 2007, Radiology.

[63]  Gerald A Kirk,et al.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. , 2007, AJR. American journal of roentgenology.

[64]  V. Runge,et al.  Nephrogenic Systemic Fibrosis: A Review of 6 Cases Temporally Related to Gadodiamide Injection (Omniscan) , 2007, Investigative radiology.

[65]  H. Thomsen.  European Society of Urogenital Radiology guidelines on contrast media application , 2007, Current opinion in urology.

[66]  J. Zic,et al.  Gadolinium deposition in nephrogenic fibrosing dermopathy. , 2007, Journal of the American Academy of Dermatology.

[67]  S. Cowper,et al.  Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. , 2007, Journal of the American Academy of Dermatology.

[68]  M. Port,et al.  Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review , 2006, Fundamental & clinical pharmacology.

[69]  H. Thomsen.  Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide , 2006, European Radiology.

[70]  Lone Skov,et al.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. , 2006, Journal of the American Society of Nephrology : JASN.

[71]  M. Zand,et al.  Nephrogenic Systemic Fibrosis Among Liver Transplant Recipients: A Single Institution Experience and Topic Update , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[72]  F. Shellock,et al.  Vagus Nerve Stimulation Therapy System: In Vitro Evaluation of Magnetic Resonance Imaging‐Related Heating and Function at 1.5 and 3 Tesla , 2006, Neuromodulation : journal of the International Neuromodulation Society.

[73]  H. Litt,et al.  Do we need pacemakers resistant to magnetic resonance imaging? , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  T. Grobner.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[75]  M. Tweedle,et al.  Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass Spectroscopy , 2006, Investigative radiology.

[76]  Daniel S Berman,et al.  Cardiac pacemaker: in vitro assessment at 1.5 T. , 2006, American heart journal.

[77]  F. Shellock,et al.  MRI and implanted medical devices: basic interactions with an emphasis on heating , 2005, IEEE Transactions on Device and Materials Reliability.

[78]  Georg Frese,et al.  Specific Absorption Rate as a Poor Indicator of Magnetic Resonance-Related Implant Heating , 2005, Investigative radiology.

[79]  Peter Boesiger,et al.  In vivo heating of pacemaker leads during magnetic resonance imaging. , 2005, European heart journal.

[80]  John R. Vacca,et al.  Defense in Depth: Firewall Topologies , 2005 .

[81]  Welcome Guimera,et al.  Practice Guidelines for Sedation and Analgesia by Non- Anesthesiologists , 2005 .

[82]  J. Loewy,et al.  Reconsideration of pacemakers and MR imaging. , 2004, Radiographics.

[83]  Mark S. Mirotznik,et al.  Numerical evaluation of heating of the human head due to magnetic resonance imaging , 2004, IEEE Transactions on Biomedical Engineering.

[84]  J. Felmlee,et al.  American College of Radiology White Paper on MR Safety: 2004 update and revisions. , 2004, AJR. American journal of roentgenology.

[85]  P. Boesiger,et al.  Safety considerations for magnetic resonance imaging of pacemaker and ICD patients , 2004, Herzschrittmachertherapie und Elektrophysiologie.

[86]  R. Fennell,et al.  Nephrogenic fibrosing dermopathy in pediatric patients , 2004, Pediatric Nephrology.

[87]  M. Lishner.  Cancer in pregnancy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  J. Felmlee,et al.  American College of Radiology White Paper on MR Safety: 2004 update and revisions. , 2004, AJR. American journal of roentgenology.

[89]  P. Walson,et al.  Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: addendum. , 2002, Pediatrics.

[90]  Ergin Atalar,et al.  of the 23 rd Annual EMBS International Conference , October 25-28 , Istanbul , Turkey RF Safety of Wires in Interventional MRI : Using a Safety Index , 2004 .

[91]  G. Chaljub,et al.  Projectile cylinder accidents resulting from the presence of ferromagnetic nitrous oxide or oxygen tanks in the MR suite. , 2001, AJR. American journal of roentgenology.

[92]  T. Kumazaki,et al.  Safety of gadolinium contrast agent in hemodialysis patients. , 2001, Acta radiologica.

[93]  Patient death illustrates the importance of adhering to safety precautions in magnetic resonance environments. , 2001, Healthcare hazard management monitor : HHMM : the newsletter of the Center for Healthcare Environmental Management.

[94]  P. Leboit,et al.  Scleromyxoedema-like cutaneous diseases in renal-dialysis patients , 2000, The Lancet.

[95]  M. Konings,et al.  Heating Around Intravascular Guidewires by Resonating RF Waves , 2000, Journal of magnetic resonance imaging : JMRI.

[96]  F. Shellock.  Pocket Guide to MR Procedures and Metallic Objects: Update 2001 , 2000 .

[97]  Radiographic screening for orbital foreign bodies prior to MR imaging: is it worth it? , 2000, AJNR. American journal of neuroradiology.

[98]  C. McDonnell,et al.  Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging. , 2000, AJNR. American journal of neuroradiology.

[99]  K. Higashino,et al.  Permeability of iodinated and MR contrast media through two types of hemodialysis membrane. , 1999, European journal of radiology.

[100]  O. Gandhi,et al.  Specific absorption rates and induced current densities for an anatomy‐based model of the human for exposure to time‐varying magnetic fields of MRI , 1999, Magnetic resonance in medicine.

[101]  H. Thomsen,et al.  Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. , 1998, Academic radiology.

[102]  L. Berlin,et al.  Standard of care. , 1998, AJR. American journal of roentgenology.

[103]  Mark J. Rieumont,et al.  Pocket Guide to MR Procedures and Metallic Objects: Update 1994 , 1995 .

[104]  C. Patterson,et al.  Joint Commission on Accreditation of Healthcare Organizations. , 1995 .

[105]  F. Shellock.  Pocket Guide to MR Procedures and Metallic Objects : Update 1994 , 1994 .

[106]  Emanuel Kanal,et al.  Guidelines and recommendations for MR imaging safety and patient management III. Questionnaire for screening patients before MR procedures , 1994, Journal of magnetic resonance imaging : JMRI.

[107]  F. Shellock,et al.  Survey of reproductive health among female MR workers. , 1993, Radiology.

[108]  F. Shellock,et al.  Policies, guidelines, and recommendations for MR imaging safety and patient management , 2005 .

[109]  F. Shellock,et al.  Policies, guidelines, and recommendations for MR imaging safety and patient management , 1991, Journal of magnetic resonance imaging : JMRI.

[110]  H. S. Osborne,et al.  The international electrotechnical commission , 1953, Electrical Engineering.

[111]  Test Method for Measurement of Magnetically Induced Displacement Force on Medical Devices in the Magnetic Resonance Environment , 2022 .